13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 59 holding rows worth $269,068,258.
- Accession
- 0001826434-23-000006
- Filer
- CIK 1826434
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 59 entries on the cover page, a total value of $269,068,258 stated on the cover page (in dollars after the unit check, H1), rows summing to $269,068,258 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 54,369 | $25,497,974 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 127,362 | $21,080,958 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 1,039,474 | $17,130,532 | dollars as filed | |
| WEST PHARMACEUTICAL SVSC INC COM | 955306105 | Stock | 40,558 | $15,512,218 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 20,644 | $14,833,540 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 200,080 | $14,377,749 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 160,660 | $14,154,146 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 96,274 | $9,816,097 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 200,997 | $8,715,230 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 24,597 | $8,655,930 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,105,770 | $8,326,448 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 116,768 | $8,060,495 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 4,099,943 | $7,953,889 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 40,832 | $7,655,592 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 51,798 | $6,656,561 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 113,441 | $6,595,460 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 198,532 | $6,450,305 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 26,010 | $6,008,310 | dollars as filed | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 176,359 | $5,710,504 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 297,807 | $5,619,618 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 4,884,621 | $5,617,314 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 29,506 | $5,604,370 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 331,992 | $3,412,878 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 151,194 | $3,196,241 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 165,897 | $3,143,748 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 370,877 | $3,052,318 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 101,691 | $2,677,524 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 52,964 | $2,577,228 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 202,406 | $2,040,252 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 57,800 | $1,895,840 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 224,074 | $1,866,536 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 108,928 | $1,748,294 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 428,307 | $1,409,130 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 41,292 | $1,312,673 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 158,413 | $991,665 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 82,052 | $946,880 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 24,221 | $932,509 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 33,750 | $932,175 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 24,201 | $874,382 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 16,462 | $821,783 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 66,885 | $791,918 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 70,588 | $772,939 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 73,067 | $613,032 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 15,268 | $396,357 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 122,500 | $330,750 | dollars as filed | put |
| AMPHENOL CORP NEW | 032095101 | COM | 2,629 | $223,334 | dollars as filed | |
| DOVER CORP COM | 260003108 | Stock | 1,512 | $223,247 | dollars as filed | |
| HARTFORD INSURANCE GROUP INC COM | 416515104 | Stock | 3,034 | $218,509 | dollars as filed | |
| PRUDENTIAL FINL INC COM | 744320102 | Stock | 2,463 | $217,286 | dollars as filed | |
| COLGATE PALMOLIVE CO COM | 194162103 | Stock | 2,701 | $208,085 | dollars as filed | |
| CINTAS CORP COM | 172908105 | Stock | 414 | $205,791 | dollars as filed | |
| Berkshire Hathaway Inc | 084670702 | COM | 588 | $200,508 | dollars as filed | |
| KINDER MORGAN INC DEL COM | 49456B101 | Stock | 10,324 | $177,779 | dollars as filed | |
| ANTERO MIDSTREAM CORP COM | 03676B102 | Stock | 11,675 | $135,430 | dollars as filed | |
| RITHM CAPITAL CORP COM NEW | 64828T201 | REIT | 13,531 | $126,515 | dollars as filed | |
| JETBLUE AWYS CORP | 477143101 | COM | 13,891 | $123,074 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 10,379 | $103,582 | dollars as filed | |
| UNDER ARMOUR INC | 904311206 | CL C | 11,603 | $77,856 | dollars as filed | |
| FEMASYS INC | 31447E105 | cs | 111,706 | $56,970 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-23-000006 | this filing | 2023-08-14 | acceptance time not in the bulk data set |